SRPT
SareptaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SRPT Profile
Sarepta Therapeutics, Inc.
A commercial-stage biopharmaceutical company focused on unique RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities
215 First Street, Suite 415, Cambridge, MA 02142
--
Sarepta Therapeutics, Inc., was incorporated in Oregon on July 22, 1980. The company is a commercial-stage biopharmaceutical company focused on helping patients by discovering and developing unique RNA-targeted therapies, gene therapies and other gene therapy models for the treatment of rare diseases. Applying their proprietary, highly differentiated and innovative technologies, and through cooperation with strategic partners, the company has developed several approved products for the treatment of Duchenne muscular dystrophy and is developing potential therapeutic candidates for a wide range of diseases and disorders, including Duchenne, muscular dystrophy of the limb girdle and other diseases related to neuromuscular and central nervous system.
